Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
6 papers
Recent·Most cited
F. Vesuna, I. Akhrymuk, A. Smith…·V. Raman
This study shows that RK-33, a DDX3 inhibitor, reduces SARS-CoV-2 viral load across multiple variants in Calu-3 cells and downregulates SARS-CoV-2 genes and TMPRSS2 expression.
A. A. Zinn, M. Izadjoo, H. Kim…·R. M. Stoltenberg
This paper introduces a self-sterilizing PPE material that deactivates SARS-CoV-2 in 30 seconds, outperforming conventional copper configurations.
C. W. Lehman, R. Flur, K. Kehn-Hall…·R. M. Bock
This study shows that silicon nitride inactivates SARS-CoV-2 in vitro without harming Vero cells, with higher concentrations and longer exposure times leading to greater viral reduction.
R. A. Barclay, I. Akhrymuk, A. Patnaik…·B. Lepene
This paper introduces a method using Nanotrap(R) particles to improve SARS-CoV-2 detection in pooled samples, saliva, and transport medium by concentrating virus before RNA extraction.
N. P. Azouz, A. M. Klingler, V. Callahan…·M. E. Rothenberg
This study identifies alpha 1 antitrypsin (A1AT) as a TMPRSS2 inhibitor that limits SARS-CoV-2 dissemination by inhibiting extracellular proteases involved in viral entry.
S. He, A. A. Waheed, B. Hetrick…·Y. Wu
The paper shows PSGL-1 inhibits SARS-CoV and SARS-CoV-2 spike glycoprotein incorporation into pseudovirions, blocking virus attachment and infectivity.